LindahlPE, ObergKE: The effect of rotenone on respiration and its point of attack. Exp Cell Res, 1961; 23:228–237.
2.
CannonJR, TapiasV, NaHM, HonickAS, DroletRE, GreenamyreJT: A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis, 2009; 34:279–290.
3.
ChaddertonN, PalfiA, Millington-WardS, et al.: Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy. Eur J Hum Genet, 2013; 21:62–68.
4.
KimJH, KimJH, YuYS, ShinJY, LeeHY, KimKW: Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy. J Cell Mol Med, 2008; 12:2407–2415.
5.
PatelRB, KothaSR, SauersLA, MalireddyS, et al.: Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N′-bis-2-mercaptoethyl isophthalamide. Toxicol Mech Methods, 2012; 22:383–396.
6.
ClarkeD, BuchananR, GuptaN, HaleyB: Amelioration of acute mercury toxicity by a novel, non-toxic lipid soluble chelator N,N′bis-(2-mercaptoethyl)isophthalamide: effect on animal survival, health, mercury excretion and organ accumulation. Toxicol Environ Chem, 2012; 94:616–640.
7.
ChanJF, ChanKH, KaoRY, ToKK, et al.: Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect, 2013; 67:606–616.
8.
DanielJA, ChauN, Abdel-HamidMK, HuL, et al.: Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic, 2015; 16:635–654.
9.
InoueY, TanakaN, TanakaY, InoueS, et al.: Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol, 2007; 81:8722–8729.
10.
SavarinoA, BoelaertJR, CassoneA, MajoriG, et al.: Effects of chloroquine on viral infections: an old drug against today's diseases?. Lancet Infect Dis, 2003; 3:722–727.
11.
FernandezF, MorishitaW, ZunigaE, NguyenJ, et al.: Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci, 2007; 10:411–413.
12.
ColasD, ChuluunB, WarrierD, BlankM, et al.: Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome. Br J Pharmacol, 2013; 169:963–973.
13.
TrottiLM, SainiP, BliwiseDL, FreemanAA, JenkinsA, RyeDB: Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: a randomized, crossover trial. Ann Neurol, 2015; 78:454–465.
14.
SuzawaH, KikuchiS, IchikawaK, KodaA: Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol, 1992; 60:85–90.
15.
DarakhshanS, PourAB: Tranilast: a review of its therapeutic applications. Pharmacol Res, 2015; 91:15–28.
16.
JacksonJM, AlexisA, BermanB, BersonDS, TaylorS, WeissJS: Current understanding of seborrheic keratosis: prevalence, etiology, clinical presentation, diagnosis, and management. J Drugs Dermatol, 2015; 14:1119–1125.
17.
RohNK, HahnHJ, LeeYW, ChoeYB, AhnKJ: Clinical and histopathological investigation of seborrheic keratosis. Ann Dermatol, 2016; 28:152–158.
18.
NoséV: Genodermatosis affecting the skin and mucosa of the head and neck: clinicopathologic, genetic, and molecular aspect-PTEN-hamartoma tumor syndrome/cowden syndrome. Head Neck Pathol, 2016; 10:131–138.
19.
KoltaiT: Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity. F1000Res, 2015; 4:9.
20.
ChaeYK, AryaA, MalecekMK, ShinDS, et al.: Repurposing metformin for cancer treatment: current clinical studies. Oncotarget, 2016. [Epub ahead of print]; DOI: 10.1863/2/oncotarget.8194.
21.
ZhongGC, LiuY, YeYY, HaoFB, WangK, GongJP: Meta-analysis of studies using statins as a reducer for primary liver cancer risk. Sci Rep, 2016; 6:26256.
22.
DenisovaOV, SöderholmS, VirtanenS, Von SchantzC, et al.: Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro. Antimicrob Agents Chemother, 2014; 58:3689–3696.
23.
PerwitasariO, YanX, O'DonnellJ, JohnsonS, TrippRA: Repurposing kinase inhibitors as antiviral agents to control influenza A virus replication. Assay Drug Dev Technol, 2015; 13:638–649.
24.
GrasesF, RodriguezA, Costa-BauzaA: Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis. PLoS One, 2014; 9:e111184.
25.
SawamuraH, HayashiH, OnozakiK: Differential effects of prostaglandin E1 and prostaglandin E2 on growth and differentiation of murine myeloid leukemic cell line, M1. Microbiol Immunol, 1995; 39:809–815.
26.
ChoeKS, CorreaD, JaniAB, LiauwSL: The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer, 2010; 116:1820–1826.
27.
AlizadehM, SylvestreMP, ZilliT, Van NguyenT, et al.: Effect of statins and anticoagulants on prostate cancer aggressiveness. Int J Radiat Oncol Biol Phys, 2012; 83:1149–1153.
